Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Blanke

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Journal of Medical Economics|November 12, 2010
Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumorsCharles D Blanke, Daniel M Huse
Current Treatment Options in Oncology|October 13, 2006
Gastrointestinal stromal tumors: imatinib and beyondIan D Schnadig, Charles D Blanke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumoursDaniel J Renouf, Lora Wilson, Charles D Blanke
JAMA Oncology|June 7, 2017
The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US PopulationJoseph M Unger, Michael LeBlanc, Charles D Blanke
JAMA Oncology|July 17, 2015
Losing "Losing the Battle With Cancer"Lee M Ellis, Charles D Blanke, Nancy Roach
Cancer|February 10, 2017
Words matter: Restoring respect and dignity when referring to individuals with cancerLee M Ellis, Charles D Blanke, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2023
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private PartnershipsRoy S Herbst, Charles D Blanke, Ellen V Sigal
American Journal of Hematology|May 16, 2003
Pulmonary and intracerebral plasmacytomas in a patient without multiple myeloma: a case reportBrandon Hayes-Lattin, Charles D Blanke, Thomas G Deloughery
Journal of Managed Care Pharmacy : JMCP|November 18, 2004
Targeted therapies in the treatment of colorectal cancer: what managed care needs to knowRowena N Schwartz, Charles D Blanke, Larry John Pesko
Southern Medical Journal|April 17, 2008
Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiencyJoseph S Chan, Cary O Harding, Charles D Blanke
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Journal of Medical Economics|November 12, 2010
Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumorsCharles D Blanke, Daniel M Huse
Current Treatment Options in Oncology|October 13, 2006
Gastrointestinal stromal tumors: imatinib and beyondIan D Schnadig, Charles D Blanke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumoursDaniel J Renouf, Lora Wilson, Charles D Blanke
JAMA Oncology|June 7, 2017
The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US PopulationJoseph M Unger, Michael LeBlanc, Charles D Blanke
JAMA Oncology|July 17, 2015
Losing "Losing the Battle With Cancer"Lee M Ellis, Charles D Blanke, Nancy Roach
Cancer|February 10, 2017
Words matter: Restoring respect and dignity when referring to individuals with cancerLee M Ellis, Charles D Blanke, Elise C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2023
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private PartnershipsRoy S Herbst, Charles D Blanke, Ellen V Sigal
American Journal of Hematology|May 16, 2003
Pulmonary and intracerebral plasmacytomas in a patient without multiple myeloma: a case reportBrandon Hayes-Lattin, Charles D Blanke, Thomas G Deloughery
Journal of Managed Care Pharmacy : JMCP|November 18, 2004
Targeted therapies in the treatment of colorectal cancer: what managed care needs to knowRowena N Schwartz, Charles D Blanke, Larry John Pesko
Southern Medical Journal|April 17, 2008
Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiencyJoseph S Chan, Cary O Harding, Charles D Blanke
Pageof 16